Company Filing History:
1 out of 832,912 Years Active: 2011
Title: Innovations by Thierry Walli
Introduction
Thierry Walli is an accomplished inventor based in Clarens, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the area of immunomodulation. His work focuses on the development of novel compositions that leverage the properties of fetal hemoglobin and bacterial endotoxin.
Latest Patents
Thierry Walli holds a patent for a composition comprising fetal hemoglobin and bacterial endotoxin, along with optional additional fetal liver components. This innovative pharmaceutical composition represents a novel immunomodulating principle. It has been discovered that the combination of endotoxin and fetal hemoglobin partial structures exhibits a pronounced synergistic biomedical activity. The biomedical effect is not based on the classical function of hemoglobin as an oxygen transporter but rather on the modulation of endotoxin-mediated bioactivity. This composition can be administered orally and has potential applications in treating allergic conditions, malignancies, chronic infections, autoimmune phenomena, and age-related imbalances. He has 1 patent to his name.
Career Highlights
Throughout his career, Thierry Walli has focused on advancing the understanding of immunomodulation through innovative pharmaceutical compositions. His research has led to significant insights into the biomedical activities of fetal hemoglobin and its derivatives.
Collaborations
Thierry Walli has collaborated with notable individuals in his field, including Otto Westphal and Josette Westphal, who serves as a legal representative.
Conclusion
Thierry Walli's contributions to the field of immunomodulation through his innovative patent highlight the potential for new treatments in various medical conditions. His work continues to pave the way for advancements in pharmaceutical compositions that can significantly impact patient care.